A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2011
11/10/2011	US20110275639 C5aR ANTAGONISTS
11/10/2011	US20110275632 Method for preventing or treating a disease related to the glucocorticoid receptor
11/10/2011	US20110275631 Heteroaryl Substituted Indole Compounds Useful as MMP-13 Inhibitors
11/10/2011	US20110275630 Isoindolinone kinase inhibitors
11/10/2011	US20110275629 Pyridazino-pyridinone Compounds and Methods of Use
11/10/2011	US20110275628 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
11/10/2011	US20110275626 Formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules
11/10/2011	US20110275625 Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/10/2011	US20110275624 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
11/10/2011	US20110275620 Method for preventing or treating a disease related to the glucocorticoid receptor
11/10/2011	US20110275619 Inhibitors of bace1 and methods for treating alzheimer's disease
11/10/2011	US20110275616 Combination Analgesic Employing Opioid and Neutral Antagonist
11/10/2011	US20110275615 Novel substituted amides, their preparation and use
11/10/2011	US20110275606 Substituted porphyrins
11/10/2011	US20110275604 Aminoalkylsterol compounds with antitumoral and neuroprotective activity
11/10/2011	US20110275600 Methods for increasing endogenous plasmalogen levels
11/10/2011	US20110275591 Cocktail for modulation of alzheimer's disease
11/10/2011	US20110275575 Peptide inhibitors of protein kinase c
11/10/2011	US20110275569 Proteases targeting agents
11/10/2011	US20110275555 Compositions containing delta-9-thc-amino acid esters and process of preparation
11/10/2011	US20110274774 System and method for assessing traditional medicines
11/10/2011	US20110274773 Copper(I) Chloride Complex Of Nicotinic Acid And Pharmaceutical Compositions Containing The Same
11/10/2011	US20110274762 Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivate
11/10/2011	US20110274760 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
11/10/2011	US20110274750 Enteric formulation of duloxetine and its core and prepration method
11/10/2011	US20110274749 Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers
11/10/2011	US20110274743 Medicament for the Treatment of Pain and Inflammation
11/10/2011	US20110274718 System for Modulating Expression of Hypothalmic Brain-Derived Neurotrophic Factor (BDNF)
11/10/2011	US20110274704 Compositions and Methods of Use of Immunotoxins Comprising Ranpirnase (Rap) Show Potent Cytotoxic Activity
11/10/2011	US20110274698 Immunomodulation Of Inflammatory Conditions Utilizing Follistatin-Like Protein-1 And Agents That Bind Thereto
11/10/2011	US20110274696 Antibodies to ccr2
11/10/2011	US20110274683 Antibodies That Bind CSF1R
11/10/2011	US20110274680 Chemical composition and its delivery for lowering the risks of alzheimer's, cardiov ascular and type-2 diabetes diseases
11/10/2011	US20110274674 Ischemic tissue cell therapy
11/10/2011	US20110274672 Sialic acid producing bacteria
11/10/2011	US20110274657 Oxadiazole derivatives as s1p1 receptor antagonists
11/10/2011	US20110274653 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells
11/10/2011	US20110274647 IL6R/IL6 Chimera for Therapy of Chemotherapy-Induced Peripheral Neuropathy
11/10/2011	US20110274638 Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics
11/10/2011	US20110274628 Nicotine-containing pharmaceutical compositions
11/10/2011	US20110274625 Liposomal Composition for Convection-Enhanced Delivery to the Central Nervous Centre
11/10/2011	US20110274623 Stabilized Fibronectin Domain Compositions, Methods and Uses
11/10/2011	US20110274616 4-(2,6-dichloro-benzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors
11/10/2011	CA2812526A1 Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
11/10/2011	CA2797050A1 Pharmaceutical composition for inhibiting apoptosis of neuron or neurodegeneration
11/10/2011	CA2795596A1 Agents for treating alzheimer's disease
11/09/2011	EP2385064A2 Agents disrupting a growth factor complex
11/09/2011	EP2385063A2 Growth factor complex
11/09/2011	EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011	EP2385032A1 GPR40 Receptor function regulator
11/09/2011	EP2384768A1 Phenylpropionamide compounds and the use thereof
11/09/2011	EP2384757A1 Prevention and/ortreatment of neurodegenerative disorders
11/09/2011	EP2384755A1 Eslicarbazepine acetate and methods of use
11/09/2011	EP2384753A1 Hydantoin derivatives as inhibitors of cellular necrosis
11/09/2011	EP2384648A1 New compositions containing omega 3 and usage to treat hangover
11/09/2011	EP2384334A1 A method of producing a novel opioid peptide
11/09/2011	EP2384328A1 6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and process for preparing them
11/09/2011	EP2146713B1 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of cranial traumas
11/09/2011	EP2131843B1 Process for the synthesis of glyt-1 inhibitors
11/09/2011	EP2035001B1 Stable laquinimod preparations
11/09/2011	EP1982721B1 Method of stabilizing s-adenosyl-l-methionine and stabilized composition
11/09/2011	EP1789021B1 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof
11/09/2011	EP1583529B1 Amino acid phenoxy ethers, their preparation and uses
11/09/2011	EP1328624B1 B7-like molecules and uses thereof
11/09/2011	EP1313769B2 Antibodies to human il-1 beta
11/09/2011	DE202009018261U1 Johanniskrautextrakte zur Behandlung von neurodegenerativen Erkrankungen St. John's wort extracts for the treatment of neurodegenerative diseases
11/09/2011	CN1946456B Alcohol metabolism moderating composition
11/09/2011	CN1931219B Gynostemma pentaphylla micro emulsion medicine and its preparation
11/09/2011	CN1696300B Arachidonic acid and methods for the production and use thereof
11/09/2011	CN1681512B Use of 2,3-benzodiazepines in preparing medicine for treatment of basal ganglia-related movement disorders
11/09/2011	CN1248288B Nuclear transfer with differentiated fetal and adult donor cells
11/09/2011	CN102239180A Antibodies to ccr2
11/09/2011	CN102239170A Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
11/09/2011	CN102239168A Substituted piperidine spiro pyrrolidinone and piperidinones used as h3 modulators
11/09/2011	CN102239164A 2h-chromene compound and derivative thereof
11/09/2011	CN102239162A Pyridazinone derivatives
11/09/2011	CN102239159A 7-piperidinoalkyl-3,4-dihydroquinolone derivative
11/09/2011	CN102239152A Novel amide derivative and use thereof as medicine
11/09/2011	CN102239146A Novel compounds as calcium channel blockers
11/09/2011	CN102238951A Pharmaceutical agent comprising quinolone compound
11/09/2011	CN102234316A Polypeptides capable of enhancement of acid sensing ion channels 1a current, and use thereof
11/09/2011	CN102234315A Modified endomorphin-1 compound and application in easing pain thereof
11/09/2011	CN102234275A Deuterated imidazo [1, 2-a] pyridine derivative for treating insomnia, its preparation method and applications
11/09/2011	CN102234273A Ziprasidone mesylate semihydrate and preparation method thereof
11/09/2011	CN102233128A Use of p75neurotrophin receptor-extracellular domain (p75NTR-ECD) in medicine for preventing and treating Alzheimer disease
11/09/2011	CN102233125A Compound flos magnoliae granule
11/09/2011	CN102233115A Traditional Chinese medicine preparation for treating gastropathy
11/09/2011	CN102233085A External application drug for treating skin diseases
11/09/2011	CN102233073A Preparation method of flavonoid extract of rhizoma arisaematis
11/09/2011	CN102233071A Traditional Chinese medicine composition for treating depression and preparation method thereof
11/09/2011	CN102233042A Traditional Chinese medicine ointment for treating trigeminal neuralgia
11/09/2011	CN102233025A Sucrose-free traditional Chinese medicinal antialcoholic beverage rich in nutrition
11/09/2011	CN102233018A Pawpaw leaven of carica papaya and rosaceae plants as well as preparation method and application thereof
11/09/2011	CN102233009A Chinese medicinal composition for promoting nerve regeneration and preparation method and use thereof
11/09/2011	CN102233000A Meizugao external ointment and preparation method thereof
11/09/2011	CN102232994A Method for preparing total phenols of Lignum Sappan
11/09/2011	CN102232993A Method for extracting general flavone from herba desmodii styracifolii
11/09/2011	CN102232990A Gynostemma pentaphylla blood tonifying nutrient solution and preparation method thereof
11/09/2011	CN102232981A Determination method of content of radix serratulae total sterone
11/09/2011	CN102232980A Preparation method for eleutheroside

1 ... 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 ... 1833